Plain-English translation of NCT03146884 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term research study designed to collect detailed health information from people living with autoimmune hepatitis in Switzerland. Researchers will track your health over time through regular visits and blood samples, creating a valuable database that helps scientists understand this rare disease better and develop better treatments.
Autoimmune hepatitis is rare, which makes it hard for doctors to understand how it progresses and which treatments work best for different patients. This study aims to gather high-quality information to answer important questions about the disease and improve care.
You likely qualify if…
You likely don't qualify if…
You will have an initial enrollment visit, then return for follow-up appointments at least once a year. If you were recently diagnosed, you'll also have an extra visit 6 months after diagnosis. At each visit, you'll have blood drawn for research and may optionally contribute a small liver tissue sample if one is collected as part of your regular care. The study aims to follow you over time to track how you respond to treatment.
AI-generated summary from trial data · Jun 29, 2026 · Not medical advice
Switzerland